Neuron loss in APP transgenic mice

Calhoun, Michael E., Wiederhold, Karl-Heinz, Abramowski, Dorothee, Phinney, Amie L., Probst, Alphonse, Sturchler-Pierrat, Christine, Staufenbiel, Matthias, Sommer, Bernd +1 more·1998·Nature

Cited by (501)

Items 301–400 of 501

  1. Transgenic Animals in Alzheimer's Disease Research
    Christine Sturchler, Bernd Sommer · 1999 · Reviews in the Neurosciences
  2. Animal models of Alzheimer’s disease: preclinical insights and challenges
    Qingqing Xu, Wen Yang, Mei Zhong, Zhi‐Xiu Lin, Nora E. Gray, Yan‐Fang Xian · 2023 · Acta Materia Medica
  3. Of mice and men: more neurobiology in dementia
    Alina Codita, Bengt G. Winblad, Abdul Hafeez Mohammed · 2006 · Current Opinion in Psychiatry
  4. β-Amyloid Plaques Induce Neuritic Dystrophy of Nitric Oxide-Producing Neurons in a Transgenic Mouse Model of Alzheimer's Disease
    Joseph F. Quinn, Forrest Davis, William R. Woodward, Felix P. Eckenstein · 2001 · Experimental Neurology
  5. PHF and PHF-like fibrils –cause or consequence?
    Ihara, Y · 2001 · Neurobiology of Aging
  6. Anti-inflammatory substances – a new therapeutic option in Alzheimer's disease
    M. Hüll · 1999 · Drug Discovery Today
  7. Neuron loss in the mouse hippocampus following prenatal injection of tritiated thymidine or saline
    Christoph Schmitz, Eva Bültmann, Monika Gube, Hubert Korr · 1999 · International Journal of Developmental Neuroscience
  8. Low−dose ionizing radiation alleviates Aβ42−induced cell death via regulating AKT and p38 pathways inDrosophilaAlzheimer′s disease models
    Soojin Hwang, Haemin Jeong, Eun‐Hee Hong, Hae Mi Joo, Kyoung Sang Cho, Seon Young Nam · 2019 · Biology Open
  9. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP+PS1 transgenic mouse brains
    A. Amritraj, Cheryl A. Hawkes, Amie L. Phinney, Howard T.J. Mount, Carolyn D. Scott, David A. Westaway, Satyabrata Kar · 2007 · Neurobiology of Aging
  10. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons
    Ulrich G�rtner, M. K. Br�ckner, Sabine Krug, Stefanie Schmetsdorf, Matthias Staufenbiel, Thomas Arendt · 2003 · Acta Neuropathologica
  11. Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis
    Karen Duff · 2001 · Biochemical Society Symposia
  12. Current Concepts and Future Prospects for Alzheimer Disease Vaccines
    Frank L. Heppner, Sam Gandy, JoAnne McLaurin · 2004 · Alzheimer Disease & Associated Disorders
  13. In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol
    Anniina Snellman, Johanna Rokka, Francisco R. Lopez‐Picon, Olli Eskola, Mario Salmona, Gianluigi Forloni, Mika Scheinin, Olof H. Solin, Juha O. Rinne, Merja Haaparanta‐Solin · 2014 · EJNMMI Research
  14. Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation
    Juliette Ezpeleta, Vincent Baudouin, Zaira E. Arellano-Anaya, François Boudet-Devaud, Mathéa Pietri, Anne Baudry, Anne‐Marie Haeberlé, Yannick J. R. Bailly, Odile Kellermann, Jean‐Marie Launay et al. · 2019 · Nature Communications
  15. The Lesion Analysis of Cholinergic Neurons in 5XFAD Mouse Model in the Three-Dimensional Level of Whole Brain
    Huanhuan Yan, Pei Pang, Wenqi Chen, Houze Zhu, Henok Kessete Afewerky, Hao Li, Zuoze Wu, Xiao Ke, Jianhua Wu, Tongmei Zhang et al. · 2017 · Molecular Neurobiology
  16. No difference between estimated mean nuclear volumes of various types of neurons in the mouse brain obtained on either isotropic uniform random sections or conventional frontal or sagittal sections
    Christoph Schmitz, D Schuster, Peter Niessen, Hubert Korr · 1999 · Journal of Neuroscience Methods
  17. Design-based counting techniques: the real problems
    Christoph Schmitz, Hubert Korr, Helmut Heinsen · 1999 · Trends in Neurosciences
  18. Microvascular basis of cognitive impairment in type 1 diabetes
    Sorabh Sharma, Craig E. Brown · 2021 · Pharmacology & Therapeutics
  19. Cell Cultures From Animal Models of Alzheimer's Disease as a Tool for Faster Screening and Testing of Drug Efficacy
    Fabrizio Trinchese, Shumin Liu, Ipe Ninan, Daniela Puzzo, Joel P. Jacob, Ottavio Arancio · 2004 · Journal of Molecular Neuroscience
  20. Building a More Perfect Beast
    Dennis W. Dickson · 2004 · American Journal Of Pathology
  21. Erratum to: The Lesion Analysis of Cholinergic Neurons in 5XFAD Mouse Model in the Three-Dimensional Level of Whole Brain
    Huanhuan Yan, Pei Pang, Wenqi Chen, Houze Zhu, Henok Kessete Afewerky, Hao Li, Zuoze Wu, Xiao Ke, Jianhua Wu, Tongmei Zhang et al. · 2017 · Molecular Neurobiology
  22. A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice
    Sally Kelliny, Liying Lin, Isaac Bul Deng, Jing Xiong, Fiona H. Zhou, Mohammed Al‐Hawwas, Larisa Bobrovskaya, Xin‐Fu Zhou · 2021 · Molecular Neurobiology
  23. Amyloid, memory and neurogenesis
    David Morgan · 2007 · Experimental Neurology
  24. Selectively vulnerable deep cortical layer 5/6 fast-spiking interneurons in Alzheimer’s disease models in vivo
    Amalia Papanikolaou, David R. Graykowski, Byung Il Lee, Mengke Yang, Robert A. Ellingford, Jana Zünkler, Suraya A Bond, James M Rowland, Rikesh M. Rajani, Sam Harris et al. · 2025 · Neuron
  25. Reduction of hippocampal N‐acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons
    Wei Xu, Yanqiang Zhan, Wei Huang, Xuxia Wang, Sumin Zhang, Hao Chuan Lei · 2010 · Journal of Neuroscience Research
  26. Metals and oxidative homeostasis in Alzheimer's disease
    George L. Perry, Ayla Cash, Ravi Srinivas, Mark A. Smith · 2002 · Drug Development Research
  27. Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution
    Rubina Marzagalli, Gian Marco Leggio, Claudio Bucolo, Elisabetta P. Pricoco, Kevin A. Keay, Venera Cardile, Sergio Castorina, Salvatore Salomone, Filippo Drago, Alessandro Castorina · 2015 · Neuroscience
  28. Coexisting Cholinergic and Parahippocampal Degeneration: A Key to Memory Loss in Dementia and a Challenge for Transgenic Models?
    Jean‐Christophe Cassel, Chantal Mathis, Mark J. Majchrzak, Pierre‐Henri Moreau, John C. Dalrymple‐Alford · 2008 · Neurodegenerative Diseases
  29. In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models
    Makoto Higuchi, Jun Maeda, Bin Ji, Masahiro Maruyama, Takashi Okauchi, Masaki Tokunaga, Maiko Ono, Tetsuya Suhara · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  30. Mitochondrial Genome Lesions in the Pathogenesis of Sporadic Alzheimer’s Disease
    W. Meier‐Ruge, Carlo Bertoni–Freddari · 1999 · Gerontology
  31. Transgenic Alzheimer Mice Have a Larger Minimum Alveolar Anesthetic Concentration of Isoflurane than Their Nontransgenic Littermates
    Barbara A. Eckel, Martina Richtsfeld, Laura Starker, Manfred Blobner · 2010 · Anesthesia & Analgesia
  32. Análisis morfológico de la región del hipocampo asociado a una tarea conductual innata en el modelo de ratón transgénico (3xTg-AD) para la enfermedad de Alzheimer
    Erika Orta‐Salazar, Alfredo Feria‐Velasco, G.I. Medina-Aguirre, Sofía Y. Díaz-Cintra · 2013 · Neurología
  33. A brief update on physical and optical disector applications and sectioning-staining methods in neuroscience
    Kıymet Kübra Yurt, Elfide Gizem Kıvrak, Gamze Altun, Hamza Mohamed, Fathelrahman Ali, Hosam Eldeen Elsadig Gasmalla, Süleyman Kaplan · 2018 · Journal of Chemical Neuroanatomy
  34. Characterization of a 3xTg‐AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background
    Jessica Virgili, Meryem Lebbadi, Cyntia Tremblay, Isabelle St‐Amour, Caroline Pierrisnard, Audrey Faucher-Genest, Vincent Émond, Carl Julien, Frédéric Calon · 2018 · Synapse
  35. Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice
    Marie-Caroline Côtel, Thomas A. Bayer, Oliver Wirths · 2008 · Brain Research
  36. Animal Models of Dementia
    Dong‐Hee Choi, Jongmin Lee · 2011 · Brain & Neurorehabilitation
  37. A Computational Model for Neocortical Neuronogenesis Predicts Ethanol-Induced Neocortical Neuron Number Deficits
    Julia M. Gohlke, W. C. Griffith, Scott M. Bartell, Thomas A. Lewandowski, Elaine M. Faustman · 2002 · Developmental Neuroscience
  38. Navigating Alzheimer’s Disease Mouse Models: Age-Related Pathology and Cognitive Deficits
    Laura Maria De Plano, Alessandra Saitta, Salvatore Oddo, Antonella Caccamo · 2024 · Biomolecules
  39. Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer’s disease
    Islam, Anam, Saito, Takashi, Saido, Takaomi, Ali, Afia B. · 2023 · Seminars in Cell & Developmental Biology
  40. Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
    Victor James Drew, Chanung Wang, Tae Kim · 2023 · Frontiers in Aging Neuroscience
  41. Morphological analysis of the hippocampal region associated with an innate behaviour task in the transgenic mouse model (3xTg-AD) for Alzheimer disease
    Erika Orta‐Salazar, Alfredo Feria‐Velasco, G.I. Medina-Aguirre, Sofía Y. Díaz-Cintra · 2013 · Neurología (English Edition)
  42. Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA
    Yann Sénéchal, Laetitia Prut, Peter H. Kelly, Matthias Staufenbiel, François Natt, Daniël Hoyer, Christoph Wießner, Kumlesh Kumar Dev · 2008 · Brain Research
  43. P3‐292: Grape seed polyphenolic extract specifically decreases Aβ∗56 in the brains of Tg2576 mice
    Peng Liu, Linda Kotilinek, Lisa J. Kemper, Jun Wang, Kathleen R. Zahs, Karen H. Ashe, Giulio Maria Pasinetti · 2010 · Alzheimer s & Dementia
  44. Amyloid β protein deposition and neuron loss in osteopetrotic (op/op) mice
    Masato Kaku, Keisuke Tsutsui, Masahide Motokawa, Toshitsugu Kawata, Tadashi Fujita, Shinya Kohno, Yuiko Tohma, Junji Ohtani, Kaoru Tenjoh, Kazuo Tanne · 2003 · Brain Research Protocols
  45. Immunotherapy for Alzheimer's Disease
    Patrick L. McGeer, Edith G. McGeer · 2004 · Science of Aging Knowledge Environment
  46. Chronic ramelteon treatment in a mouse model of Alzheimer's disease.
    James Timothy McKenna, Michael A. Christie, Brianne A Jeffrey, John G. McCoy, Eunho Lee, Nina P. Connolly, Christopher Peyton Ward, Robert E. Strecker · 2012 · PubMed
  47. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice
    Jasmin Mahler, José Morales‐Corraliza, Julia Stolz, Angelos Skodras, Rebecca Radde, Carmen Cecilia Duma, Yvonne S. Eisele, Matthew J. Mazzella, Harrison K. A. Wong, William Edward Klunk et al. · 2015 · Neurobiology of Aging
  48. Region-specific neuron and synapse loss in the hippocampus of APPSL/PS1 knock-in mice
    Ivona Brasnjevic, Roy Lardenoije, Christoph Schmitz, Nicolien M. van der Kolk, Dara L. Dickstein, Hisaaki Takahashi, Patrick R. Hof, Harry W.M. Steinbusch, Bart P. F. Rutten · 2013 · Translational Neuroscience
  49. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice
    Karthikeyan Balakrishnan, Ajeet Rijal Upadhaya, Julia L. Steinmetz, Julia Reichwald, Dorothée Abramowski, Marcus Fändrich, Sathish Kumar, Haruyasu Yamaguchi, Jochen Walter, Matthias Staufenbiel et al. · 2015 · Acta Neuropathologica Communications
  50. Evaluation of the APP23-model for Alzheimer's disease in the odour paired-associate test for hippocampus-dependent memory
    Annemie Van Dijck, Ellen Vloeberghs, Debby Van Dam, Matthias Staufenbiel, Peter Paul De Deyn · 2008 · Behavioural Brain Research
  51. Regulation of Alzheimer ß-Amyloid Precursor Trafficking and Metabolism
    Sam Gandy, Suzana S. Petanceska · 2001 · Advances in experimental medicine and biology
  52. CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer’s Disease
    Tatiana Brustovetsky, Rajesh Khanna, Nickolay Brustovetsky · 2023 · Cells
  53. Conditionally inducible tau mice – designing a better mouse model of neurodegenerative diseases
    Christopher Janus · 2008 · Genes Brain & Behavior
  54. Statistical aspects of quantitative image analysis of β-amyloid in the APPV717F transgenic mouse model of Alzheimer's disease
    Cindy E. Fishman, David J. Cummins, Kelly R. Bales, Cynthia A. DeLong, Michail A. Esterman, Jeffery C. Hanson, Sandy L. White, Steven M. Paul, William H. Jordan · 2001 · Journal of Neuroscience Methods
  55. The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders
    Sujan Kumar Sarkar, Carolina Gubert, Anthony John Hannan · 2025 · Neuroscience & Biobehavioral Reviews
  56. Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
    Xinyue Li, Meina Quan, Yiping Wei, Wei Wang, Lingzhi Xu, Qi Wang, Jianping Jia · 2023 · Science China Life Sciences
  57. miR-277 targets the proapoptotic gene-hid to ameliorate Aβ42-mediated neurodegeneration in Alzheimer’s model
    Prajakta Deshpande, Chao‐Yi Chen, Anuradha Venkatakrishnan Chimata, Jian‐Chiuan Li, Ankita Sarkar, Catherine J. Yeates, Chun‐Hong Chen, Madhuri Kango‐Singh, Amit Singh · 2024 · Cell Death and Disease
  58. Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
    Xing Fang, Fan Fan, Richard J. Roman · 2024 · Journal of Experimental Neurology
  59. Brain regions and genes affecting myoclonus in animals
    Robert Lalonde, C. Strazielle · 2012 · Neuroscience Research
  60. Prospects for Early Detection of Alzheimers Disease from Serial MR Images in Transgenic Mouse Models
    Michael Muskulus, Alize E. H. Scheenstra, Niels Braakman, Jouke Dijkstra, Sjoerd M. Verduyn Lunel, A. Alia, Huub J. M. de Groot, Johan H. C. Reiber · 2009 · Current Alzheimer Research
  61. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice
    Ajeet Rijal Upadhaya, Frederik Scheibe, Irina Kosterin, Dorothée Abramowski, Janina Gerth, Sathish Kumar, Stefan Liebau, Haruyasu Yamaguchi, Jochen Walter, Matthias Staufenbiel et al. · 2013 · Acta Neuropathologica Communications
  62. Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice
    Patricia Szot, Debby Van Dam, Sylvia S. White, Allyn A. Franklin, Matthias Staufenbiel, Peter Paul De Deyn · 2009 · Neuroscience Letters
  63. Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology
    Satyabrata Kar · 2002 · Drug Development Research
  64. Aging, microglia and cytoskeletal regulation are key factors in the pathological evolution of the APP23 mouse model for Alzheimer's disease
    Leen Janssen, Marissa Lisa Dubbelaar, Inge R. Holtman, Jelkje J. de Boer-Bergsma, Bart J. L. Eggen, H. W. G. M. Boddeke, Peter Paul De Deyn, Debby Van Dam · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  65. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
    Michael Klonarakis, Maya De Vos, Emma K. Woo, Liam T. Ralph, Jonathan S. Thacker, Joana Gil‐Mohapel · 2022 · Neuroscience & Biobehavioral Reviews
  66. Endoplasmic reticulum stress contributes to the decline in doublecortin expression in the immature neurons of mice with long-term obesity
    Kiyomi Nakagawa, S. Islam, M. Ueda, Toshiyuki Nakagawa · 2022 · Scientific Reports
  67. Effects of isoflurane-induced anaesthesia on cognitive performance in a mouse model of Alzheimerʼs disease
    Barbara A. Eckel, Frauke Ohl, Laura Starker, Gerhard Rammes, Ralph Bogdanski, Eberhard Friedrich Kochs, Manfred Blobner · 2012 · European Journal of Anaesthesiology
  68. Role of hippocalcin in mediating Aβ toxicity
    Yun-An Lim, Maria Giese, Claire E. Shepherd, Glenda Margaret Halliday, Masaaki Kobayashi, Ken Takamatsu, Matthias Staufenbiel, Anne Eckert, Jürgen Götz · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  69. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals
    Federico d’Oleire Uquillas, Heidi I.L. Jacobs, Bernard Jimmy Hanseeuw, Gad A. Marshall, Michael J Properzi, Aaron P. Schultz, Molly R. LaPoint, Keith A. Johnson, Reisa Anne Sperling, Patrizia Vannini · 2017 · NeuroImage Clinical
  70. Development of a humanized C1q A chain knock-in mouse: Assessment of antibody independent ß-amyloid induced complement activation
    Ming Li, Rahasson R. Ager, Deborah A. Fraser, Natalia O. Tjokro, Andrea J. Tenner · 2008 · Molecular Immunology
  71. Tph2 Genetic Ablation Contributes to Senile Plaque Load and Astrogliosis in APP/PS1 Mice
    Chao‐Jin Xu, Jun-Ling Wang, Jing-Pan, Min-Liao · 2019 · Current Alzheimer Research
  72. Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease
    Wei Lü, Yang Shu, Lei Zhang, Lin Chen, Feng‐lei Chao, Yanmin Luo, Qian Xiao, Hengwei Gu, Rong Jiang, Yong Cheng Tang · 2016 · Current Alzheimer Research
  73. MAP1B 1–126 interacts with tubulin isoforms and induces neurite outgrowth and neuronal death of cultured cortical neurons
    Fujiya Gomi, Yoko Uchida · 2011 · Brain Research
  74. Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease
    Sophia G. Antimisiaris, Spyridon Mourtas, Eleni Markoutsa, Αθανάσιος Σκούρας, Κωνσταντίνα Παπαδιά · 2014 · Advanced Healthcare Materials
  75. Influence of Transgenic Metallothionein-1 on Gliosis, CA1 Neuronal Loss, and Brain Metal Levels of the Tg2576 Mouse Model of Alzheimer’s Disease
    Comes, Gemma, Manso, Yasmina, Escrig, Anna, Fernandez-Gayol, Olaya, Sanchis, Paula, Molinero, Amalia, Giralt, Mercedes, Carrasco, Javier, Hidalgo, Juan · 2017 · International Journal of Molecular Sciences
  76. Quantification of β-Amyloidosis and rCBF with Dedicated PET, 7 T MR Imaging, and High-Resolution Microscopic MR Imaging at 16.4 T in APP23 Mice
    Florian C. Maier, Marianne Keller, Daniel Bukala, Benjamin Bender, Julia G. Mannheim, Ian M. Brereton, Graham John Galloway, Bernd Jürgen Pichler · 2015 · Journal of Nuclear Medicine
  77. Impaired hypoxic tolerance in APP 23 mice: a dysregulation of neuroprotective globin levels
    Zoë P. Van Acker, Evi Luyckx, Wendy Van Leuven, Eva Geuens, Peter Paul De Deyn, Debby Van Dam, Sylvia Dewilde · 2017 · FEBS Letters
  78. Recent advances in transgenic model development for Alzheimer's disease
    Bernd Sommer · 1998 · Expert Opinion on Investigational Drugs
  79. Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research
    Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, Carsten Culmsee, Jean-Christophe Delpech, Martin Feldotto, Jorine Geertsema, Emmy E. Hoeksema, Anikó Kőrösi, Sophie Layé et al. · 2025 · Progress in Neurobiology
  80. Animal Models in Biomedical Research
    Fred William Quimby · 2002 · Elsevier eBooks
  81. Single-Cell Microwell Platform Reveals Circulating Neural Cells as a Clinical Indicator for Patients with Blood-Brain Barrier Breakdown
    Yu Zhang, Antony R. Warden, Khan Zara Ahmad, Yanlei Liu, Xijun He, Min-qiao Zheng, Xinlong Huo, Xiao Zhi, Yuqing Ke, Hongxia Li et al. · 2021 · Research
  82. Time-course global proteome analyses reveal an inverse correlation between Aβ burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease
    Hansen Wang, Declan Williams, Jennifer K. Griffin, Takashi Saito, Takaomi C. Saido, Paul E. Fraser, Ekaterina A. Rogaeva, Gerold Schmitt‐Ulms · 2017 · PLoS ONE
  83. Modeling developmental processes in animals: applications in neurodevelopmental toxicology
    Elaine M. Faustman, Julia M. Gohlke, Nancy L. Judd, Thomas A. Lewandowski, Scott M. Bartell, William C. Griffith · 2005 · Environmental Toxicology and Pharmacology
  84. Cholinergic Neurons of the Rodent Basal Forebrain and Their Content of Estrogen Receptor Alpha
    Giedrius Kalesnykas · 2005
  85. Loss of Cholinergic and Monoaminergic Afferents in APPswe/PS1ΔE9 Transgenic Mouse Model of Cerebral Amyloidosis Preferentially Occurs Near Amyloid Plaques
    Michael K. Lee, Gang Chen · 2024 · International Journal of Molecular Sciences
  86. GADD34 suppresses eIF2α phosphorylation and improves cognitive function in Alzheimer's disease-model mice
    Miki Hayakawa-Ogura, Tana Tana, Toshiyuki Nakagawa, Masanori Itoh · 2023 · Biochemical and Biophysical Research Communications
  87. Dietary Quercetin Ameliorates Memory Impairment in a Murine Model of Alzheimer’s Disease with Obesity and Diabetes, Suppressing ATF4 Expression
    Kiyomi Nakagawa, Masashi Ueda, Masanori Itoh, Saiful Islam, Tana Tana, Toshiyuki Nakagawa · 2017 · Journal of Neurology and Neuroscience
  88. The emerging utility of animal models of chronic neurodegenerative diseases
    Philipp J. Kahle, Christian Haass · 2001 · Emerging Therapeutic Targets
  89. An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease
    Paula A. Lopes, Mafalda Soares Pádua, José Luis Guil‐Guerrero · 2025 · Journal of dementia and Alzheimer's disease
  90. Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer’s Disease
    Oldham CE, Dayami Lopez · 2018 · International Journal of Biomedical Investigation
  91. A diet at amyloid beta
    James A Josepha, George Perry, B. Shukitt-Hale, N. Denisova, Antonio Martín, Mark A. Smith · 2001 · Neurobiology of Aging
  92. Mechanism of Neuronal Death in Alzheimer’s Disease
    Michael C. Irizarry · 2002 · Advances in behavioral biology
  93. Cognitive Impairment in Transgenic Mouse Models of Amyloid Deposition
    David Morgan · 2006 · Frontiers in neuroscience
  94. Validation of a functional human AD model with four AD therapeutics utilizing patterned ipsc-derived cortical neurons integrated with microelectrode arrays
    Julbert Caneus, Kaveena Autar, Nesar Akanda, Marcella Grillo, Christopher J. Long, Max Jackson, Sarah Lindquist, Xiufang Guo, David Morgan, James J. Hickman · 2024 · Scientific Reports
  95. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation
    Yasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Toshiya Nomura, Yukio Ando, Mitsuharu Ueda · 2022 · Cellular and Molecular Life Sciences
  96. Neuronal cell death in human neurodegenerative diseases and their animal/cell models
    Lee J. Martin, Zhiping Liu, Juan Carlos Troncoso, Donald L. Price · 2005 · Cambridge University Press eBooks
  97. Cognitive Impairment in Transgenic Mouse Models of Amyloid Deposition
    Edward D. Levin, Jerry J. Buccafusco · 2006 · CRC Press eBooks
  98. Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer’s Disease Combined with Cerebral Hypoperfusion
    Zhihong Bian, Xinran Hu, Xia Liu, Haibo Yu, Yuting Bian, Hongming Sun, Yusuke Fukui, Ryuta Morihara, Hiroyuki Ishiura, Toru Yamashita · 2023 · Journal of Alzheimer s Disease
  99. The early changes in behavior and the myelinated fibers of the white matter in the Tg2576 transgenic mouse model of Alzheimer's disease
    Lei Zhang, Wei Lü, Lin Chen, Xuan Qiu, Chen Li, Chunxia Huang, Xia Gong, Qi-cheng Min, Fang Lu, Jingyuan Wan et al. · 2013 · Neuroscience Letters
  100. Brain-invading monocytes promote seizure-associated cognitive deficits and neurodegeneration
    Soheila Pourkhodadad, Wenyi Wang, Raymond J Dingledine, Nicholas H. Varvel · 2025 · Neuropharmacology